Science News: Chemotherapy-Induced Peripheral Neuropathy: A Current Review 11/30/2017
Submitted by John C. Kincaid, MD, News Science Editorial Board
Edited by Niranjan N. Singh, MD, News Science Editorial Board
In the June 2017 edition of Annals of Neurology, Dr. Staff and his colleagues from Mayo Clinic in Rochester, Minnesota published a very detailed review article on chemotherapy-induced peripheral neuropathy (CIPN) which is a sensory predominant painful condition seen in 30-40 percent of patients receiving neurotoxic chemotherapy agents. In this review, they discuss the approach to peripheral neuropathy in patients with cancer and address the clinical phenotype and pathomechanism of specific neurotoxic chemotherapeutic agents and treatment options.